FDA Inspection 786574 — King Pharmaceuticals LLC

King Pharmaceuticals LLC — FEI 1876582

The FDA completed an inspection of King Pharmaceuticals LLC on June 15, 2012 in Rochester, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 15, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rochester, MI (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
144821 CFR 211.111Establishment of time limitations